4.5 Interactions with other medicinal products and other forms of interactions 
 Live attenuated virus vaccines 
 Immunoglobulin ad ministration may impair for a period of at least 6weeks and up to 3months theefficacy of live attenuated virus vaccines such as measles , rubella, mumps and varicella. Aft er administration o f this product, an interval of 3months should elapse before vac cination with live attenuated virus vaccines. In the c ase of measles, this impairment may persist for up to 1year. Therefore patients receiving measles vaccine should have their antibody stat us checked.Dilution of KIOVIG with a 5% glucose solution may resultin increased blood glucose levels.Loop diureti cs 
 Avoidance of concomitant use of loop diuretics .Paediatric population 
 The listed interactions apply both to adult s and children .
4.6Fertility, p regnancy and lactation 
 Pregnancy 
 The safety of t his medicinal product for use in human pregnancy has n ot been established in controlled clinical trials and therefore it should only be given with caution to pregnant women and breast -feeding mothers. IVIg products have been shown to cross the placenta, in creasingly during the third trimester .Clinical experi ence with immunoglobulins suggests that no harmful effects on the course of pregnancy, or on the foetus and the neonate are to be expected .Breast -feeding 
 Immunoglobulins are excreted into the milk an dmay contribute to protecting the neonate from pathog ens which have a mucosal portal of entry. No negative effects on the breastfed newborn/infants are anticipated.Fertil ity 
 Clinical exper ience with immunoglobulins suggests that no harmful effects on f ertility are to be expected.
4.7 Effects on ability t o drive and use machines 
 The ability to drive and operate machines may be impaired by some adverse reactions associate d with KIOVIG. Pati ents who experience adverse reactions during treatment should wa itfor these to resolve before driving or operating ma chines